DAFNA Capital Management LLC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 148 filers reported holding ARCUS BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.5%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$3,997,770
-12.8%
222,717
-1.3%
1.24%
-0.7%
Q2 2023$4,584,312
+43.4%
225,717
+28.8%
1.25%
+30.8%
Q1 2023$3,195,958
+8.7%
175,217
+23.2%
0.96%
+15.7%
Q4 2022$2,941,048
-37.1%
142,217
-20.4%
0.83%
-34.1%
Q3 2022$4,675,000
-1.7%
178,717
-4.8%
1.26%
-3.1%
Q2 2022$4,757,000
+3.8%
187,717
+29.3%
1.30%
+8.6%
Q1 2022$4,583,000
-3.4%
145,217
+23.9%
1.19%
+0.1%
Q4 2021$4,743,000
+10.0%
117,200
-5.3%
1.19%
+4.3%
Q3 2021$4,313,000
+31.2%
123,700
+3.3%
1.14%
+66.5%
Q2 2021$3,287,000
+103.3%
119,700
+107.8%
0.69%
+78.9%
Q1 2021$1,617,000
+25.5%
57,600
+16.1%
0.38%
+0.3%
Q4 2020$1,288,000
+4.2%
49,600
-31.2%
0.38%
-4.7%
Q3 2020$1,236,000
-30.7%
72,1000.0%0.40%
-21.9%
Q2 2020$1,784,000
+362.2%
72,100
+159.4%
0.52%
+219.9%
Q1 2020$386,000
+232.8%
27,798
+270.6%
0.16%
+187.5%
Q1 2018$116,0007,5000.06%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders